Genmab
GMAB
17,27 €
Share price
0.78%
Change (1 day)
-37.66%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2024 (TTM): €2.88 Billion
According to Genmab's latest financial reports the company's current revenue (TTM 
) is €2.75 Billion. an increase over the revenue in the year 2023 that were of €2.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €2.98 B | 38.41% |
| 2023 | €2.15 B | 12.56% |
| 2022 | €1.91 B | 63.87% |
| 2021 | €1.16 B | -8.07% |
| 2020 | €1.27 B | 77.39% |
| 2019 | €0.71 B | 72.69% |
| 2018 | €0.41 B | 34.46% |
| 2017 | €0.30 B | 22.53% |
| 2016 | €0.25 B | 64.23% |
| 2015 | €0.15 B | 25.83% |
| 2014 | €0.12 B | 41.94% |
| 2013 | €85.9 M | 34.13% |
| 2012 | €64.04 M | 28.27% |
| 2011 | €49.92 M | -35.35% |
| 2010 | €77.23 M | 1.33% |
| 2009 | €76.21 M |